Genomics

Provider of genomic risk assessment and prevention platform

placeLondon, England, United Kingdom calendar_todayFounded 2014 language genomics.com

Registered entities

Investor mix

19 investors on record; lead investors include F-Prime Capital, Foresite Capital, Vertex Pharmaceuticals, IP Group.

Investor typeCountShare
Venture capital632%
Private equity211%
Accelerator & incubator211%
Bank & private debt15%
Other / undisclosed842%
Coming soon